|
[1]JAIME B, YASUKO I.The portal hypertension syndrome:etiology, classification, relevance, and animal models[J].Hepatol Int, 2018, 12 (Suppl 1) :s1-s10.
|
|
[2]OLIVER TI, JOHN S.Hypertension, Portal.Stat Pearls[M].Treasure Island (FL) :Stat Pearls Publishing, 2018.
|
|
[3]Working Subgroup for Clinical Practice Guideline for Aberrant Portal Hemodynamics.Diagnosis and treatment guidelines for aberrant portal hemodynamics:The Aberrant Portal Hemodynamics Study Group supported by the Ministry of Health, Labor and Welfare of Japan[J].Hepatol Res, 2017, 47 (5) :373-386.
|
|
[4]MARTENS P, NEVENS F.Budd-Chiari syndrome[J].United Eur Gastroenterol, 2015, 3 (6) :489-500.
|
|
[5]Chinese Medical Association Chinese Society of Radiology (CSR) Interventional Group.Guidelines of the interventional treatment for Budd-Chiari syndrome[J].Chin J Radiol, 2010, 44 (4) :345-349. (in Chinese) 中华医学会放射学分会介入学组.布加综合征介入诊疗规范的专家共识[J].中华放射学杂志, 2010, 44 (4) :345-349.
|
|
[6]Expert Committee on Vena Cava Obstruction, Specialized Committee of Endovascology, Chinese Medical Doctor Association.Expert consensus on the classification of subtypes in Budd-Chiari syndrome[J].J Clin Hepatol, 2017, 33 (7) :1229-1235. (in Chinese) 中国医师协会腔内血管学分会腔静脉阻塞专家委员会.布-加综合征亚型分型的专家共识[J].临床肝胆病杂志, 2017, 33 (7) :1229-1235.
|
|
[7]QI X, HAN G, GUO X, et al.Review article:The aetiology of primary Budd-Chiari syndrome-differences between the West and China[J].Aliment Pharmacol Ther, 2016, 44 (11-12) :1152-1167.
|
|
[8]PLESSIER A, RAUTOU PE, VALLA DC.Management of hepatic vascular diseases[J].J Hepatol, 2012, 56 (Suppl 1) :s25-s38.
|
|
[9]LANGLET P, ESCOLANO S, VALLA D, et al.Clinicopathological forms and prognostic index in Budd-Chiari syndrome[J].J Hepatol, 2003, 39 (4) :496-501.
|
|
[10]VALLA DC.Primary Budd-Chiari syndrome[J].J Hepatol, 2009, 50 (1) :195-203.
|
|
[11]van WETTERE M, BRUNO O, RAUTOU PE, et al.Diagnosis of Budd-Chiari syndrome[J].AbdomRadiol (NY) , 2018, 43 (8) :1896-1907.
|
|
[12]WANG ZG.Wang Zhonghao vascular surgery[M].Hangzhou:Zhejiang Science and Technology Press, 2010:629-630. (in Chinese) 汪忠镐.汪忠镐血管外科学[M].杭州:浙江科学技术出版社, 2010:629-630.
|
|
[13]ZHOU P, REN J, HAN X, et al.Initial imaging analysis of Budd-Chiari syndrome in Henan province of China:most cases have combined inferior vena cava and hepatic veins involvement[J].PLo S One, 2014, 9 (1) :e85135.
|
|
[14]FLOR N, ZUIN M, BROVELLI F, et al.Regenerative nodules in patients with chronic Budd-Chiari syndrome:a longitudinal study using multiphase contrast-enhanced multidetector CT[J].Eur J Radiol, 2010, 73 (3) :588-593.
|
|
[15]de GOTTARDI A, BERZIGOTTI A, BUSCARINI E, et al.Ultrasonography in liver vascular disease[J].Ultraschall Med, 2018, 39 (4) :382-405.
|
|
[16]ZHANG LM, ZHANG GY, LIU YL, et al.Ultrasonography and computed tomography diagnostic evaluation of Budd-Chiari syndrome based on radical resection exploration results[J].Ultrasound Q, 2015, 31 (2) :124-129.
|
|
[17]MARUYAMA H, YOKOSUKA O.Ultrasonography for noninvasive assessment of portal hypertension[J].Gut Liver, 2017, 11 (4) :464-473.
|
|
[18]LU L, XU K, HAN C, et al.Comparison of 3.0T MRI with 3DLAVA sequence and digital subtraction angiography for the assessment of accessory hepatic veins in Budd-Chiari syndrome[J].J MagnReson Imaging, 2017, 45 (2) :401-409.
|
|
[19]YANG C, LI C, ZENG M, et al.Non-contrast-enhanced MRangiography in the diagnosis of Budd-Chiari syndrome (BCS) compared with digital subtraction angiography (DSA) :Preliminary results[J].MagnReson Imaging, 2017, 36:7-11.
|
|
[20]GRUS T, LAMBERT L, GRUSOVA G, et al.Budd-Chiari Syndrome[J].Prague Med Rep, 2017, 118 (2-3) :69-80.
|
|
[21]European Association for the Study of the Liver.EASL clinical practice guidelines:Vascular diseases of the liver[J].J Hepatol, 2016, 64 (1) :179-202.
|
|
[22]de FRANCHIS R.Expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension[J].J Hepatol, 2015, 63 (3) :743-752.
|
|
[23]SEIJO S, PLESSIER A, HOEKSTRA J, et al.Good long-term outcome of Budd-Chiari syndrome with a step-wise management[J].Hepatology, 2013, 57 (5) :1962-1968.
|
|
[24]PLESSIER A, SIBERT A, CONSIGNY Y, et al.Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome[J].Hepatology, 2006, 44 (5) :1308-1316.
|
|
[25]PAREKH J, MATEI VM, CANAS-COTO A, et al.Budd-Chiari syndrome causing acute liver failure:A multi-center case series[J].Liver Transpl, 2017, 23 (2) :135-142.
|
|
[26]DE GA, TREBICKA J, KLINGER C, et al.Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis[J].Liver Int, 2017, 37 (5) :694-699.
|
|
[27]TRIPATHI D, SUNDERRAJ L, VEMALA V, et al.Long-term outcomes following percutaneous hepatic vein recanalization for Budd-Chiari syndrome[J].Liver Int, 2017, 37 (1) :111-120.
|
|
[28]SHARMA S, TEXEIRA A, TEXEIRA P, et al.Pharmacological thrombolysis in Budd Chiari syndrome:A single centre experience andreview of the literature[J].J Hepatol, 2004, 40 (1) :172-180.
|
|
[29]SMALBERG JH, SPAANDER MV, JIE KS, et al.Risks and benefits of transcatheter thrombolytic therapy in patients with splanchnic venous thrombosis[J].Thromb Haemost, 2008, 100 (6) :1084-1088.
|
|
[30]TRIPATHI D, MACNICHOLAS R, KOTHARI C, et al.Good clinical outcomes fol owing transjugular intrahepatic portosystemic stentshunts in Budd-Chiari syndrome[J].Aliment Pharmacol Ther, 2014, 39 (8) :864-872.
|
|
[31]HERNANDEZ-GUERRA M, TURNES J, RUBINSTEIN P, et al.PTFE-covered stents improve TIPS patency in BuddChiari syndrome[J].Hepatology, 2004, 40 (5) :1197-1202.
|
|
[32]MANCUSO A.An update on management of Budd-Chiari syndrome[J].Ann Hepatol, 2014, 13 (3) :323-326.
|
|
[33]PETERSEN BD, CLARK TW.Direct intrahepatic portocaval shunt[J].Tech Vasc Interv Radiol, 2008, 11 (4) :230-234.
|
|
[34]HATZIDAKIS A, GALANAKIS N, KEHAGIAS E, et al.Ultrasound-guided direct intrahepatic portosystemic shunt in patients with Budd-Chiari syndrome:Short-and long-term results[J].Interv Med Appl Sci, 2017, 9 (2) :86-93.
|
|
[35]MENTHA G, GIOSTRA E, MAJNO PE, et al.Liver transplantation for Budd-Chiari syndrome:A European study on 248 patients from 51 centres[J].J Hepatol, 2006, 44 (3) :520-528.
|
|
[36]SEGEV DL, NGUYEN GC, LOCKE JE, et al.Twenty years of liver transplantation for Budd-Chiari syndrome:A national registry analysis[J].Liver Transpl, 2007, 13 (9) :1285-1294.
|
|
[37]POTTHOFF A, ATTIA D, PISCHKE S, et al.Long-term outcome of liver transplant patients with Budd-Chiari syndrome secondary to myeloproliferative neoplasms[J].Liver Int, 2015, 35 (8) :2042-2049.
|
|
[38]WESTBROOK RH, LEA NC, MOHAMEDALI AM, et al.Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation[J].Liver Transpl, 2012, 18 (7) :819-827.
|
|
[39]CHINNAKOTLA S, KLINTMALM GB, KIM P, et al.Long-term follow-up of liver transplantation for Budd-Chiari syndrome with antithrombotic therapy based on the etiology[J].Transplantation, 2011, 92 (3) :341-345.
|
|
[40]KONSTAM MA, KIERNAN MS, BERNSTEIN D, et al.Evaluation and management of right-sided heart failure:A scientific statement from the american heart association[J].Circulation, 2018, 137 (20) :e578-e622.
|
|
[41]WELCH TD.Constrictive pericarditis:Diagnosis, management and clinical outcomes[J].Heart, 2018, 104 (9) :725-731.
|
|
[42]ADLER Y, CHARRON P, IMAZIO M, et al.2015 ESC Guidelines for the diagnosis and management of pericardial diseases:The task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) Endorsed by:The European Association for Cardio-Thoracic Surgery (EACTS) [J].Eur Heart J, 2015, 36 (42) :2921-2964.
|
|
[43]SYED FF, SCHAFF HV, OH JK.Constrictive pericarditis-a curable diastolic heart failure[J].Nat Rev Cardiol, 2014, 11 (9) :530-544.
|
|
[44]CHOWDHURY UK, SUBRAMANIAM GK, KUMAR AS, et al.Pericardiectomy for constrictivepericarditis:A clinical, echocardiographic, and hemodynamic evaluation of two surgical techniques[J].Ann Thorac Surg, 2006, 81 (2) :522-529.
|
|
[45]BERTOG SC, THAMBIDORAI SK, PARAKH K, et al.Constrictive pericarditis:Etiology and cause-specific survival after pericardiectomy[J].J Am Coll Cardiol, 2004, 43 (8) :1445-1452.
|
|
[46]LING LH, OH JK, SCHAFF HV, et al.Constrictive pericarditis in the modern era:Evolving clinical spectrum and impact on outcome after pericardiectomy[J].Circulation, 1999, 100 (13) :1380-1386.
|
|
[47]KOMODA T, FRUMKIN A, KNOSALLA C, et al.Child-Pugh score predicts survival after radical pericardiectomy for constrictive pericarditis[J].Ann Thorac Surg, 2013, 96 (5) :1679-1685.
|
DownLoad: